bioRxivCell Biology
Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation
J. Kang, R. Pearson, H. Zhu, K. T. Chan, X. Huang, S. Blake, A. S. Trigos, D. Anderson, D. J. S. Creek, D. P. De Souza, X. Wang, C. Fu, M. Jana, E. Sanij
Abstract
Hyperactivation of oncogenic pathways downstream of RAS and PI3K/AKT in normal cells induces a senescence-like phenotype that acts as a tumor-suppressive mechanism that must be overcome during transformation. We previously demonstrated that AKT-induced senescence (AIS) is associated with profound transcriptional and metabolic changes. Here, we demonstrate that human fibroblasts undergoing AIS display increased Cystathionine-{beta}-synthase (CBS) expression and consequent activation of the transsulfuration pathway controlling hydrogen sulfide (H2S) and glutathione (GSH) metabolism. Activated transsulfuration pathway during AIS maintenance enhances the antioxidant capacity, protecting senescent cells from ROS-induced cell death via GSH and H2S. Importantly, CBS depletion allows cells that have undergone AIS to escape senescence and re-enter the cell cycle, indicating the importance of CBS activity in maintaining AIS. Mechanistically, we show this restoration of proliferation is mediated through suppressing mitochondrial respiration and reactive oxygen species (ROS) production and increasing GSH metabolism. These findings implicate a potential tumor-suppressive role for CBS in cells with inappropriately activated PI3K/AKT signaling. Consistent with this concept, in human gastric cancer cells with activated PI3K/AKT signaling, we demonstrate that CBS expression is suppressed due to promoter hypermethylation. CBS loss cooperates with activated PI3K/AKT signaling in promoting anchorage-independent growth of gastric epithelial cells, while CBS restoration suppresses the growth of gastric tumors in vivo. Taken together, we find that CBS is a novel regulator of AIS and a potential tumor suppressor in PI3K/AKT-driven gastric cancers, providing a new exploitable metabolic vulnerability in these cancers.
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cystathionine Beta-Synthase Promotes Anoikis Resistance and Transcoelomic Metastasis in Ovarian Cancer via SP1- ITGB1 regulation
Pallab Shaw, Arpan Dey Bhowmik, … Geeta Rao·DOAJ (DOAJ: Directory of Open Access Journals)Peer-reviewed·Jul 1, 2026
- Disrupting Akt-Wnt/β-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice
Md Marzan Sarkar, Nathan Gonsalves, … Steven L. Stice·Journal of Neuro-OncologyPeer-reviewed·Mar 1, 2026
- AKT1 is Required for a Complete Palbociclib-induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma
A. L. Bayer, J. Pietruska, … P. W. Hinds·bioRxiv·Dec 2, 2021
- ESCRT-dependent YAP degradation by AKT blockade overcomes adaptive resistance to RAS(ON) inhibition in pancreatobiliary cancer
Jack W. Sample, Enis Özmert, … Rory L. Smoot·bioRxiv·Oct 20, 2026
- Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hub
Jacob Neumann, Wen-Hsuan Chang, … Marc A. Antonyak·bioRxiv·Oct 23, 2026
- Loss of PKCtheta-GADD45a axis drives triple-negative breast cancer cells into p53-independent senescence
Amandine Nicolle, Ye Zhang, … Karine Belguise·bioRxiv·Oct 10, 2024